Why Streamline Health Solutions Shares Are Trading Lower By Over 68%? Here Are Other Stocks Moving In Monday's Mid-Day Session
$ALDX
$ALHC
$AMAM
$APH
Biotechnology: Pharmaceutical Preparations
Health Care
Medical Specialities
Health Care
Gainers
- MingZhu Logistics Holdings Limited (NASDAQ:YGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday.
- PCTEL, Inc. (NASDAQ:PCTI) climbed 47.3% to $6.86. On Friday, Amphenol Corp (NYSE:APH) inked a deal to acquire PCTEL for around $139.7 million.
- Almacenes Éxito S.A. (NYSE:EXTO) shares rose 32.6% to $6.66.
- MMTec, Inc. (NASDAQ:MTC) surged 30% to $0.7608.
- Tempest Therapeutics, Inc. (NASDAQ:TPST) gained 29% to $4.72.
- LQR House Inc. (NASDAQ:LQR) shares climbed 24.5% to $0.2148. LQR House announced that through its custom marketing campaign and strategic efforts, Von Payne Whiskey is now displayed on the shelves of the retail giant, Costco.
- Secoo Holding Limited (NASDAQ:SECO) rose 23% to $0.7868 after declining 37% on Friday.
- Ensysce Biosciences, Inc. (NASDAQ:ENSC) climbed 22.2% to $1.76.
- E2open Parent Holdings, Inc. (NYSE:ETWO) gained 22% to $3.00. Elliott Investment Management L.P. reported a 9% stake in E2open Parent Holdings as of Oct. 13.
- Inotiv, Inc. (NASDAQ:NOTV) climbed 21.2% to $2.4850.
- Zapp Electric Vehicles Group Limited (NASDAQ:ZAPP) gained 21.2% to $0.6195.
- Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) shares jumped 20.8% to $0.5799 after jumping 45% on Friday.
- Mereo BioPharma Group plc (NASDAQ:MREO) climbed 20% to $1.55. Ultragenyx and Mereo BioPharma announced interim Phase 2 data from Phase 2/3 Orbit study demonstrating setrusumab significantly reduced fracture rates in patients with osteogenesis imperfecta.
- Prothena Corporation plc (NASDAQ:PRTA) gained 19.7% to $52.78.
- Alignment Healthcare, Inc. (NASDAQ:ALHC) gained 17.8% to $7.80 after Raymond James upgraded the stock from Outperform to Strong Buy and raised its price target from $9 to $10.
- Consolidated Communications Holdings, Inc. (NASDAQ:CNSL) surged 17.5% to $4.1493 after the company announced an agreement to be acquired by Searchlight Capital Partners and British Columbia Investment Management.
- Modular Medical, Inc. (NASDAQ:MODD) gained 17.4% to $1.08.
- Catalyst Biosciences, Inc. (NASDAQ:CBIO) rose 15.5% to $0.39.
- indie Semiconductor, Inc. (NASDAQ:INDI) climbed 15% to $5.60. indie Semiconductor expects third-quarter revenue to be above $60 million, slightly higher than the company's guidance and consensus estimates.
- CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) gained 14.2% to $1.5527.
- RedHill Biopharma Ltd. (NASDAQ:RDHL) shares rose 13.8% to $0.3639 after falling 14% on Friday.
- Cardlytics, Inc. (NASDAQ:CDLX) climbed 11.9% to $12.35.
- MoonLake Immunotherapeutics (NASDAQ:MLTX) gained 11.5% to $60.98 after the company announced 24-week top-line results from its global Phase 2 MIRA trial for maintenance treatment with its Nanobody sonelokimab.
- NanoVibronix, Inc. (NASDAQ:NAOV) surged 11.5% to $1.2828.
- ATRenew Inc. (NYSE:RERE) climbed 11.3% to $1.78.
- Momentus Inc. (NASDAQ:MNTS) shares gained 10.8% to $3.4450.
- Overstock.com, Inc. (NASDAQ:OSTK) climbed 10.5% to $16.61. Overstock.com 13D filing showed JAT Capital Mgmt LP reported a 9.1% stake in the company as of Oct. 12.
- Lululemon Athletica Inc. (NASDAQ:LULU) surged 9.8% to $414.67 after it was announced the stock will join the S&P 500.
- ESSA Pharma Inc. (NASDAQ:EPIX) gained 8.4% to $2.9696.
- Snap Inc. (NYSE:SNAP) climbed 8.4% to $9.40.
Losers
- Streamline Health Solutions, Inc. (NASDAQ:STRM) shares dipped 68.2% to $0.2350 after the company announced it is undergoing a strategic restructuring to cut expenses.
- Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) shares fell 66.7% to $1.81. The company received feedback from the U.S. Food and Drug Administration (FDA) regarding their new drug application (NDA) for reproxalap, intended for treating dry eye disease.
- Biocept, Inc. (NASDAQ:BIOC) fell 46% to $0.5503. Biocept said Antonino Morales tendered his resignation as the company's President And Chief Executive Officer, effective on Oct. 13, 2023. The company also filed voluntary petition under the provisions of Chapter 7 in Bankruptcy Court.
- Omeros Corporation (NASDAQ:OMER) dropped 37.4% to $1.42 after the company announced it will discontinue the ARTEMIS-IGAN trial, which did not reach statistical significance on the primary endpoint of reduction in proteinuria from baseline compared to placebo.
- Ambrx Biopharma Inc. (NASDAQ:AMAM) fell 36.2% to $8.97. Ambrx Biopharma said that two abstracts detailing updated safety and efficacy data from the ongoing Phase 1/2 trial, APEX-01 of ARX517 for metastatic castration-resistant prostate cancer were made available at the European Society of Medical Oncology.
- The NFT Gaming Company, Inc. (NASDAQ:NFTG) declined 35.3% to $0.6255.
- Sigma Additive Solutions, Inc. (NASDAQ:SASI) fell 32.8% to $3.99 after jumping 140% on Friday.
- Shift Technologies, Inc. (NASDAQ:SFT) shares fell 30.3% to $0.11. Maruthi J. D. Venkata reported a 4.8% stake in Shift Technologies as of Oct 12, 2023 versus an 11.5% stake reported as of March 14, 2023.
- Vista Outdoor Inc. (NYSE:VSTO) declined 24.6% to $24.72 after the company lowered FY24 guidance and announced it entered into a definitive agreement to sell its sporting products business.
- RVL Pharmaceuticals plc (NASDAQ:RVLP) declined 23% to $0.0557. RVL Pharmaceuticals said on Oct. 12, that the company received delisting notice from Listing Qualifications Department of Nasdaq Stock Market LLC.
- Nexalin Technology, Inc. (NASDAQ:NXL) fell 22% to $0.3664. Nexalin Technology announced publication of groundbreaking deep-brain stimulation study in leading peer-reviewed journal.
- Elys Game Technology, Corp. (NASDAQ:ELYS) declined 21.4% to $0.4050.
- ShiftPixy, Inc. (NASDAQ:PIXY) fell 20.6% to $13.60.
- Versus Systems Inc. (NASDAQ:VS) fell 16.5% to $0.1956. Versus Systems reported pricing of $3.0 million public offering.
- Nxu, Inc. (NASDAQ:NXU) fell 15.5% to $0.0769.
- MoneyHero Limited (NASDAQ:MNY) declined 15.5% to $2.83.
- UTime Limited (NASDAQ:WTO) shares fell 12.7% to $0.2750, after gaining over 7% on Friday.
- FaZe Holdings Inc. (NASDAQ:FAZE) shares fell 11.8% to $0.2056 after jumping around 25% on Friday.
- Tango Therapeutics, Inc. (NASDAQ:TNGX) declined 11.5% to $6.80.
- Clover Health Investments, Corp. (NASDAQ:CLOV) declined 10.8% to $0.9181.
- Procaps Group S.A. (NASDAQ:PROC) fell 9.7% to $2.5444.
- Manchester United plc (NYSE:MANU) shares fell 9.5% to $18.08 after a Qatari investor group led by Sheikh Jassim Bin Hamad J.J. Al Thani reportedly withdrew its bid to acquire the club.
- Bio-Path Holdings, Inc. (NASDAQ:BPTH) shares fell 9.3% to $0.6804 after jumping around 111% on Friday.
- Novavax, Inc. (NASDAQ:NVAX) declined 7.9% to $6.49. Shares of vaccine stocks traded lower after Pfizer reduced its 2023 COVID vaccine revenue outlook.
- ParaZero Technologies Ltd. (NASDAQ:PRZO) shares fell 7.6% to $3.05, after jumping 55% on Friday.
- GameStop Corp. (NYSE:GME) declined 4.7% to $14.22. GameStop General Counsel and Secretary Haymond Mark Robinson sold a total of 11,966 shares at an average price of $15.48.
- BioNTech SE (NASDAQ:BNTX) fell 4.1% to $99.34 after the company's partner, Pfizer, cut its COVID-19 vaccine and therapy sales outlook.
Now Read This: Tesla Options Trading Surges Ahead Of Wednesday Earnings Report